Associations of Systolic Blood Pressure and Diastolic Blood Pressure With the Incidence of Coronary Artery Disease or Cerebrovascular Disease According to Glucose Status

被引:26
作者
Yamada, Mayuko Harada [1 ,2 ,3 ]
Fujihara, Kazuya [1 ]
Kodama, Satoru [1 ]
Sato, Takaaki [1 ]
Osawa, Taeko [1 ]
Yaguchi, Yuta [1 ]
Yamamoto, Masahiko [1 ]
Kitazawa, Masaru [1 ]
Matsubayashi, Yasuhiro [1 ]
Yamada, Takaho [1 ]
Seida, Hiroyasu [4 ]
Ogawa, Wataru [2 ,3 ]
Sone, Hirohito [1 ]
机构
[1] Niigata Univ, Dept Internal Med, Fac Med, Niigata, Japan
[2] Kobe Univ, Div Diabet & Endocrinol, Grad Sch Med, Kobe, Hyogo, Japan
[3] Kobe Univ, Dept Internal Med, Grad Sch Med, Kobe, Hyogo, Japan
[4] JMDC Inc, Tokyo, Japan
关键词
DIABETES-MELLITUS; CARDIOVASCULAR OUTCOMES; STANDARDIZATION; MANAGEMENT; MORTALITY; TRIAL;
D O I
10.2337/dc20-2252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To determine associations of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with new-onset coronary artery disease (CAD) or cerebrovascular disease (CVD) according to glucose status. RESEARCH DESIGN AND METHODS Examined was a nationwide claims database from 2008 to 2016 on 593,196 individuals. A Cox proportional hazards model identified risks of CAD and CVD events among five levels of SBP and DBP. RESULTS During the study period 2,240 CAD and 3,207 CVD events occurred. Compared with SBP <= 119 mmHg, which was the lowest quintile of SBP, hazard ratios (95% CI) for CAD/CVD in the 4 higher quintiles (120-129, 130-139, 140-149, >= 150 mmHg) gradually increased from 2.10 (1.73-2.56)/1.46 (1.27-1.68) in quintile 2 to 3.21 (2.37-4.34)/4.76 (3.94-5.75) in quintile 5 for normoglycemia, from 1.39 (1.14-1.69)/1.70 (1.44-2.01) in quintile 2 to 2.52 (1.95-3.26)/4.12 (3.38-5.02) in quintile 5 for borderline glycemia, and from 1.50 (1.19-1.90)/1.72 (1.31-2.26) in quintile 2 to 2.52 (1.95-3.26)/3.54 (2.66-4.70) in quintile 5 for diabetes. A similar trend was observed for DBP across 4 quintiles (75-79, 80-84, 85-89, and >= 90 mmHg) compared with >= 74 mmHg, which was the lowest quintile. CONCLUSIONS Results indicated that cardiovascular risks gradually increased with increases in SBP and DBP regardless of the presence of and degree of a glucose abnormality. Further interventional trials are required to apply findings from this cohort study to clinical practice.
引用
收藏
页码:2124 / 2131
页数:8
相关论文
共 29 条
[1]   Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study [J].
Adamsson Eryd, Samuel ;
Gudbjornsdottir, Soffia ;
Manhem, Karin ;
Rosengren, Annika ;
Svensson, Ann-Marie ;
Miftaraj, Mervete ;
Franzen, Stefan ;
Bjorck, Staffan .
BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
[2]   Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial [J].
Bress, Adam P. ;
King, Jordan B. ;
Kreider, Kathryn E. ;
Beddhu, Srinivasan ;
Simmons, Debra L. ;
Cheung, Alfred K. ;
Zhang, Yingying ;
Doumas, Michael ;
Nord, John ;
Sweeney, Mary Ellen ;
Taylor, Addison A. ;
Herring, Charles ;
Kostis, William J. ;
Powell, James ;
Rastogi, Anjay ;
Roumie, Christianne L. ;
Wiggers, Alan ;
Williams, Jonathan S. ;
Yunis, Reem ;
Zias, Athena ;
Evans, Greg W. ;
Greene, Tom ;
Rocco, Michael V. ;
Cushman, William C. ;
Reboussin, David M. ;
Feinglos, Mark N. ;
Papademetriou, Vasilios .
DIABETES CARE, 2017, 40 (10) :1401-1408
[3]   Blood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: an overview of systematic reviews [J].
Brunstrom, Mattias ;
Eliasson, Mats ;
Nilsson, Peter M. ;
Carlberg, Bo .
JOURNAL OF HYPERTENSION, 2017, 35 (03) :453-462
[4]   Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality A Systematic Review and Network Meta-analysis [J].
Bundy, Joshua D. ;
Li, Changwei ;
Stuchlik, Patrick ;
Bu, Xiaoqing ;
Kelly, Tanika N. ;
Mills, Katherine T. ;
He, Hua ;
Chen, Jing ;
Whelton, Paul K. ;
He, Jiang .
JAMA CARDIOLOGY, 2017, 2 (07) :775-781
[5]   Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus [J].
Cushman, William C. ;
Evans, Gregory W. ;
Byington, Robert P. ;
Goff, David C., Jr. ;
Grimm, Richard H., Jr. ;
Cutler, Jeffrey A. ;
Simons-Morton, Denise G. ;
Basile, Jan N. ;
Corson, Marshall A. ;
Probstfield, Jeffrey L. ;
Katz, Lois ;
Peterson, Kevin A. ;
Friedewald, William T. ;
Buse, John B. ;
Bigger, J. Thomas ;
Gerstein, Hertzel C. ;
Ismail-Beigi, Faramarz .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) :1575-1585
[6]   Microalbuminuria as an early marker for cardiovascular disease [J].
de Zeeuw, Dick ;
Parving, Hans-Henrik ;
Henning, Robert H. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (08) :2100-2105
[7]   Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease [J].
Duncan, Meredith S. ;
Freiberg, Matthew S. ;
Greevy, Robert A., Jr. ;
Kundu, Suman ;
Vasan, Ramachandran S. ;
Tindle, Hilary A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (07) :642-650
[8]   Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis [J].
Ettehad, Dena ;
Emdin, Connor A. ;
Kiran, Amit ;
Anderson, Simon G. ;
Callender, Thomas ;
Emberson, Jonathan ;
Chalmers, John ;
Rodgers, Anthony ;
Rahimi, Kazem .
LANCET, 2016, 387 (10022) :957-967
[9]  
Franklin SS, 1997, CIRCULATION, V96, P308
[10]   Impact of body mass index and metabolic phenotypes on coronary artery disease according to glucose tolerance status [J].
Fujihara, K. ;
Matsubayashi, Y. ;
Yamamoto, M. ;
Osawa, T. ;
Ishizawa, M. ;
Kaneko, M. ;
Matsunaga, S. ;
Kato, K. ;
Seida, H. ;
Yamanaka, N. ;
Kodama, S. ;
Sone, H. .
DIABETES & METABOLISM, 2017, 43 (06) :543-546